JNJ
JOHNSON&JOHNSON
Health Care·Pharmaceuticals·UNITED STATES
$254.66
MCap $613B
as of 2026-06-26
Total
B1w
Fund
C1w
Quant
B1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-27
MIDOS SI
+0.88
Sentiment 11.8%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$254.66
Adaptive Mean
$247.37
+7.29 vs mean
Adaptive σ
4.17
MIDOS BB
$239.04 – $255.70
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
+0.10
ROE
26.4%
Z +0.69
Rev Gr
9.9%
Z -0.22
EPS Gr
90.6%
Z +0.27
OPM Gr
-6.7%
Z -0.40
FCF Yld
3.2%
Z +0.26
EPS Surp
0.4%
Z -0.08
EPS 3mo Δ
-0.8%
Z +0.17
Fwd P/E
20.01
Z —
PEGY
0.06
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-27
Q3M
9.21
Q6M
12.46
Q12M
15.77
MA 30/100
0.991
Bearish (MA30 < MA100)
α (Jensen)
0.3717
β (12M)
-0.08
σ (12M)
0.178
Divergence — Fundamentals vs Momentum
Z Percentile
68%
Q Percentile
100%
Divergence
-31.8
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
15.1
RS Pctl
69%
RS Decile
D7
Persistence
1w
at grade B
Options / OI Analysis
as of 2026-06-27
OI Center
$225.95
-11.3% from spot
Max Pain
$235.00
PCR (OI)
1.13
neutral
Skew
-0.78
OI Composite
-1
neutral
Direction
strong_bearish